Items tagged with Treatment
Shortening treatment of tuberculosis: lessons from fluoroquinolone trials (post)
In clinical trial settings the standard 6-month treatment regimen for drug-sensitive pulmonary tuberculosis can achieve relapse-free cure in more than 95% of people. However, poor adherence might increase the risk of relapse and lead to drug resistance. Shortening the duration of treatment has become a major priority for global control of tuberculosis—it will benefit patients and reduce the selection pressures that lead to the evolution of new drug-resistant strains.
India: 57% of TB patients given wrong drugs (post)
MUMBAI: Here's why drug-resistant tuberculosis (TB) breeds freely in Mumbai: Patients don't get appropriate medication.
Tuberculosis: a joint MSF/Ministries of Health symposium to discuss new treatments and approaches in Eastern Europe and Central Asia (post)
A medical forum in Armenia gathers health authorities and specialists to discuss tuberculosis, one of the main public health issues in the region. New drugs and therapeutic approaches give hope of better treatment outcomes. Joint and renewed efforts are needed to obtain a better access to the most effective drugs and new treatment regimens for the resistant form of the disease.
India: Working towards personalised TB treatment (post)
Three major global research centres in India will receive funding coming out of collaboration between the UK Medical Research Council (MRC) and the Department for Biotechnology (DBT), India. The Department for Biotechnology will match the funding provided by UK through MRC and Newton Fund.
Treatment outcome of tuberculosis patients at National Hospital Abuja Nigeria: a five year retrospective study (post)
Abstract
Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study (post)
Abstract (provisional)
High-dose rifampin reduced time to TB culture conversion (post)
SEATTLE — A treatment regimen including a high dose of rifampin could reduce treatment duration for patients with tuberculosis, according to data presented at CROI 2015.
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children (post)
Abstract (provisional)
New drugs still out of reach for most in India, world TB hotspot (post)
The case of a Mumbai tailor cured of an extremely resistant form of tuberculosis this week has revived debate over a new drug to which the Indian government has limited access, prompting calls for change.
Australia grants support for TB Alliance to advance new TB drugs (post)
TB Alliance, a not-for-profit product development partnership with the mission of developing better, faster, and affordable drugs for tuberculosis (TB), has received a grant from the Australian Department of Foreign Affairs and Trade (DFAT) to support late-stage clinical trials of new TB treatments. The grant was announced at a World TB Day event in Canberra, Australia as part of a larger investment of support for new tools to tackle diseases that endanger public health in the region.
Page 10 of 108 · Total posts: 0
←First 9 10 11 Last→